Study to Assess PXL770 in Subjects With Adrenomyeloneuropathy (AMN) Form of X-linked Adrenoleukodystrophy (X-ALD or ALD)
NCT05146284
·
clinicaltrials.gov ↗
PHASE2
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class
Stopped
Lack of funding to initiate the study
Conditions
Adrenomyeloneuropathy
Interventions
DRUG:
PXL770
Sponsor
Poxel SA